Variant report
Variant | esv3423710 |
---|---|
Chromosome Location | chr17:15792252-15795100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15788370..15791029-chr17:15792412..15794241,3 | MCF-7 | breast: | |
2 | chr17:15791472..15794195-chr17:15796023..15798848,3 | K562 | blood: | |
3 | chr17:15794544..15796258-chr17:15901823..15903663,2 | MCF-7 | breast: | |
4 | chr17:15782611..15786264-chr17:15794710..15797679,3 | MCF-7 | breast: | |
5 | chr17:15794765..15797289-chr17:15822819..15824762,2 | MCF-7 | breast: | |
6 | chr17:15791535..15794057-chr17:15795691..15797755,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000214941 | chromatin interactions |
ENSG00000011295 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113289969 | chr17:15792284-15792285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541696967 | chr17:15792333-15792334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376025051 | chr17:15792393-15792394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs527449409 | chr17:15792433-15792434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540811520 | chr17:15792518-15792519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs367805712 | chr17:15792525-15792526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189965442 | chr17:15792554-15792555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs36073689 | chr17:15792641-15792642 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs144618179 | chr17:15792678-15792679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35856354 | chr17:15792728-15792729 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs532012219 | chr17:15792756-15792757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552810515 | chr17:15792809-15792810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566395192 | chr17:15792819-15792820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs180730169 | chr17:15792821-15792822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs548780161 | chr17:15792855-15792856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs568718170 | chr17:15792922-15792923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369829002 | chr17:15792925-15792926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537543563 | chr17:15792929-15792930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186164225 | chr17:15792983-15792984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557184222 | chr17:15793006-15793007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577122773 | chr17:15793068-15793069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539464351 | chr17:15793069-15793070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs552984075 | chr17:15793081-15793082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570685766 | chr17:15793098-15793099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560130996 | chr17:15793212-15793213 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542229515 | chr17:15793213-15793214 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562736643 | chr17:15793215-15793216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs138518577 | chr17:15793321-15793322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190697264 | chr17:15793339-15793340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs574299610 | chr17:15793348-15793349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183268026 | chr17:15793352-15793353 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563258016 | chr17:15793353-15793354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186423643 | chr17:15793357-15793358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190486996 | chr17:15793369-15793370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559421676 | chr17:15793374-15793375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183774905 | chr17:15793377-15793378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12935927 | chr17:15793443-15793444 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs568630069 | chr17:15793447-15793448 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56109469 | chr17:15793475-15793476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141894844 | chr17:15793529-15793530 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144606380 | chr17:15793533-15793534 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34759447 | chr17:15793629-15793630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570841665 | chr17:15793703-15793704 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539949964 | chr17:15793773-15793774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs552945270 | chr17:15793774-15793775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373030451 | chr17:15793775-15793776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58361385 | chr17:15793813-15793814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187913340 | chr17:15793814-15793815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192946734 | chr17:15793849-15793850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182458401 | chr17:15793864-15793865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 22102821 | CNVD |
Gastric cancer | 18160780 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15782600-15799000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr17:15787600-15794000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr17:15787600-15795800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr17:15787600-15796200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr17:15789400-15796000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr17:15789600-15796200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr17:15790600-15794000 | Weak transcription | Fetal Muscle Trunk | muscle |
8 | chr17:15790600-15794000 | Weak transcription | Fetal Muscle Leg | muscle |
9 | chr17:15790600-15795400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
10 | chr17:15790600-15796000 | Weak transcription | K562 | blood |
11 | chr17:15790600-15797600 | Weak transcription | Lung | lung |
12 | chr17:15790600-15800000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr17:15790800-15800800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr17:15791000-15792800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
15 | chr17:15791000-15792800 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
16 | chr17:15791000-15796200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
17 | chr17:15792600-15793800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr17:15792800-15793400 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr17:15792800-15794200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
20 | chr17:15794000-15794200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr17:15794000-15794200 | Enhancers | Esophagus | oesophagus |
22 | chr17:15794000-15794200 | Enhancers | Pancreas | Pancrea |
23 | chr17:15794000-15794200 | Enhancers | NHDF-Ad | bronchial |
24 | chr17:15794000-15794400 | Enhancers | Placenta | Placenta |
25 | chr17:15794000-15794600 | Enhancers | Fetal Muscle Trunk | muscle |
26 | chr17:15794000-15795200 | Enhancers | Fetal Muscle Leg | muscle |
27 | chr17:15794200-15795000 | Weak transcription | Pancreas | Pancrea |
28 | chr17:15794400-15796000 | Weak transcription | Placenta | Placenta |
29 | chr17:15795000-15798200 | Enhancers | Pancreas | Pancrea |